Skip to main content
Top
Published in: Journal of Gastroenterology 12/2006

01-12-2006

Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE—famotidine or rebamipide in comparison by endoscopy)

Authors: Jun-ichi Yamao, Eiryo Kikuchi, Masami Matsumoto, Masaki Nakayama, Tatsuichi Ann, Hideyuki Kojima, Akira Mitoro, Motoyuki Yoshida, Masaaki Yoshikawa, Hiroshi Yajima, Yoshizumi Miyauchi, Hiroshi Ono, Koichi Akiyama, Goro Sakurai, Yoshikazu Kinoshita, Ken Haruma, Yoshinori Takakura, Hiroshi Fukui

Published in: Journal of Gastroenterology | Issue 12/2006

Login to get access
Metadata
Title
Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE—famotidine or rebamipide in comparison by endoscopy)
Authors
Jun-ichi Yamao
Eiryo Kikuchi
Masami Matsumoto
Masaki Nakayama
Tatsuichi Ann
Hideyuki Kojima
Akira Mitoro
Motoyuki Yoshida
Masaaki Yoshikawa
Hiroshi Yajima
Yoshizumi Miyauchi
Hiroshi Ono
Koichi Akiyama
Goro Sakurai
Yoshikazu Kinoshita
Ken Haruma
Yoshinori Takakura
Hiroshi Fukui
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 12/2006
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-006-1952-5

Other articles of this Issue 12/2006

Journal of Gastroenterology 12/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine